Czechia· CZ-0245151

MEGACE

A megestrol product containing megestrol acetate, registered in Czechia by Bausch Health Ireland Limited, Dublin. The same ATC class is registered in 11 of our 19 countries.

ATC L02AB01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedMEGACEATCL02AB01REGISTER NO.CZ-0245151PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Megestrol is registered in 11 of 19 countries.

Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Megestrol · ATC L02AB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of megestrol costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Megestrol · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

  • IT Italy$2.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
MEGESTROL ACETATE
Manufacturer
Bausch Health Ireland Limited, Dublin
Country
Czechia (CZ)
ATC code
L02AB01
ATC class
Megestrol
Defined daily dose
0.16 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0245151
    1X240ML
    CZK 1531.31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

152 interactions on record for megestrol.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Megestrol · interactions on record

152 records

  • 2 severe
  • 147 moderate
  • 3 minor

Most severe, free to view

  • DofetilideC01BD04severe
  • ThalidomideL04AX02severe
  • AprepitantA04AD12moderate
  • LiraglutidA08AX02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Megestrol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All megestrol products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Belgium · Megace
  • Cyprus · Megace
  • Germany · Megestat
  • Spain · Borea, Maygace Altas Dosis
  • France · Megace
  • United Kingdom (Northern Ireland) · Megace
  • Greece · Megace
  • Croatia · Megace, Megostat
  • Hungary · Cachexi, Megace
  • Ireland · Megace
  • Italy · Gestroltex, Megace
  • Lithuania · Megace
  • Luxembourg · Megace
  • Netherlands · Megestrolacetaat Focus
  • Norway · Megace
  • Poland · Cachexan, Megace
  • Portugal · Megace, Megestrol Generis
  • Romania · Megesin
  • Sweden · Megace
  • Slovenia · Megace
  • Slovakia · Megesin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d706de67-f2af-4664-9121-1811c48a33bb
GET /v1/drugs/d706de67-f2af-4664-9121-1811c48a33bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "POR SUS",
  "source": "sukl",
  "strength": "40MG/ML",
  "pack_size": "1X240ML",
  "substance": "MEGESTROL ACETATE",
  "cz_kod_sukl": "0245151",
  "product_type": "CH",
  "substance_codes": "885",
  "registration_state": "R",
  "registration_number": "56/150/00-C"
}

See everything about megestrol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.